圣愈汤结合实测经络针灸疗法治疗乳腺增生症临床价值研究  

Study onClinical Value of Shengyu Decoction(圣愈汤)Combined with Acupuncture and Moxibustion Therapy for Meridians and Collaterals in Treatment of Mammary Hyperplasia

作　　者：何海燕 张革萍[2] 谭娟[2] 高瑞瑞 HE Haiyan;ZHANG Geping;TAN Juan;GAO Ruirui(Department of Pain,Affiliated Hospital of Yan'an University,Yan'an716000,Shaanxi,China;Department of Traditional Chinese Medicine,Affiliated Hospital of Yan'an University,Yan'an716000,Shaanxi,China)

机构地区：[1]延安大学附属医院疼痛科,陕西延安716000 [2]延安大学附属医院中医科,陕西延安716000

出　　处：《辽宁中医杂志》2021年第4期164-167,共4页Liaoning Journal of Traditional Chinese Medicine

基　　金：延安市科技惠民计划项目(SL2017KHM-092);陕西省社会发展科技攻关项目(2016SF-075)。

摘　　要：目的探究圣愈汤结合实测经络针灸疗法治疗乳腺增生症临床价值。方法研究共计纳入60例乳腺增生症(2016年10月-2018年12月收治)患者并平均分为两组,对照组患者(30例)采取三苯氧胺治疗,观察组患者(30例)西医常规加圣愈汤结合实测经络针灸疗法治疗,比较两组患者疗效、治疗前后患者乳房肿块大小变化及中医症状积分(月经异常、乳房疼痛、乳房溢液等)变化、不良反应及治疗后6个月、12个月疾病复发率、治疗满意率。结果观察组患者治疗有效率(96.67%,29/30)高于对照组(76.67%,23/30),P <0.05;治疗前,两组患者乳房肿块大小相当,P> 0.05,治疗后各组患者乳房肿块缩小,而观察组乳房肿块小于对照组,P <0.05;两组患者治疗前乳房疼痛、乳房溢液、月经异常等积分相当,P> 0.05,治疗后各组患者积分降低,观察组积分低于对照组,P <0.05;观察组与对照组不良反应率均较低,均为3.33%(1/30),P> 0.05;观察组患者6个月复发率为0.00%,与对照组(0.00%)相当(P> 0.05),12个月后复发率为0.00%,低于对照组(13.33%,14/30),观察组患者治疗满意率为100.00%,高于对照组(80.00%,24/30),P <0.05。结论圣愈汤结合实测经络针灸疗法治疗乳腺增生症临床疗效显著,患者症状改善,恢复好,不良反应少,安全可靠,且患者复发率低,治疗满意率高,值得推广以及应用。Objective To explore the clinical value of Shengyu Decoction( 圣愈汤) combined with acupuncture and moxibustion therapy for meridians and collaterals in the treatment of breast hyperplasia. Methods Sixty patients with breast hyperplasia( admitted from October 2016 to December 2018) were included in the study and divided into two groups on average. Patients in the control group( 30 cases) were treated with tamoxifen. Those in the observation group( 30 cases) were treated with conventional western medicine and Shengyu Decoction combined with acupuncture and moxibustion therapy for meridians and collaterals. The curative effect,breast mass size change and TCM symptom scores( menorrhea,breast pain,breast overflow) of the two groups before and after treatment,adverse reactions,recurrence rate of disease and satisfaction rate of treatment at 6 and 12 months after treatment were compared. Results The effective ratein the observation group( 96. 67%,29/30) was higher than that in the control group( 76. 67%,23/30)( P < 0. 05). Before treatment,the breast mass in the two groups had the same size( P > 0. 05). After treatment,the breast mass in the observation group was smaller than that in the control group( P < 0. 05). Before treatment,the scores of breast pain,breast overflow and menstrual abnormality in the two groups were the same( P > 0. 05). After treatment,the scores of patients in the observation group were lower than those in the control group( P < 0. 05). The adverse reactions in the observation group and the control group were lower( both 3. 33%,1/30,P > 0. 05). The recurrence ratein the observation group was0. 00% at 6 months,which was equivalent to that in the control group( 0. 00%)( P > 0. 05). The recurrence rate after 12 months was 0. 00%,which was lower than that in the control group( 13. 33%,4/30). The treatment satisfaction rate of patients in the observation group was 100. 00%,which was higher than that in the control group( 80. 00%,24/30)( P < 0. 05). Conclusion The clinical effect of Shengyu Decoctio

关 键 词：乳腺增生症 圣愈汤 实测经络针灸疗法 乳房肿块 复发 

分 类 号：R271.44[医药卫生—中医妇科学]